| Serial Number | 87190457 |
| Word Mark | ELIXIRGEN |
| Filing Date | Saturday, October 1, 2016 |
| Status | 701 - SECTION 8 - ACCEPTED |
| Status Date | Wednesday, September 27, 2023 |
| Registration Number | 5320821 |
| Registration Date | Tuesday, October 31, 2017 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 15, 2017 |
| Description of Mark | The mark consists of a stylized triangular geometric shape and the stylized wording "ELIXIRGEN". |
| Goods and Services | pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, Fanconi anemia, idiopathic and pulmonary fibrosis), karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, cancer; chemicals and chemical preparations for medical and pharmaceutical purposes for telomere-shortening diseases (e.g., dyskeratosis congenita, and Fanconi anemia), idiopathic pulmonary fibrosis, karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, and cancers |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 6, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, May 19, 2016 |
| First Use In Commerce Date | Thursday, May 19, 2016 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 6, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, May 19, 2016 |
| First Use In Commerce Date | Thursday, May 19, 2016 |
| Party Name | Elixirgen, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Baltimore, MD 21205 |
| Party Name | Elixirgen, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Baltimore, MD 21205 |
| Party Name | Elixirgen, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Baltimore, MD 21205 |
| Event Date | Event Description |
| Wednesday, September 27, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Wednesday, September 27, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Tuesday, September 26, 2023 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Wednesday, August 23, 2023 | POST REGISTRATION ACTION MAILED - SEC. 8 |
| Tuesday, August 22, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, March 21, 2023 | TEAS SECTION 8 RECEIVED |
| Friday, March 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, March 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, March 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, March 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 31, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, October 31, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 15, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 15, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 26, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 12, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 11, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 10, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 10, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 10, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 17, 2017 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, January 17, 2017 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, January 17, 2017 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, January 17, 2017 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, January 10, 2017 | ASSIGNED TO EXAMINER |
| Friday, October 7, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, October 6, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 5, 2016 | NEW APPLICATION ENTERED |